drugset / Trial / NCT03953703
Levocarnitine for Dry Eye in Sjogren's Syndrome
RandomizedCrossoverSingle-blindTreatment
Summary
This study evaluates the effectiveness of levocarnitine in the treatment of dry eye in adults with Sjogren's syndrome. This will be a crossover study design with all participants receiving both levocarnitine and placebo.
Timeline
- Start
- 2021-11-17
- Primary completion
- 2025-09-19
- Completion
- 2025-09-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 1000 mg | Oral |